Vaccination against human papillomavirus [5]

CMAJ. Canadian Medical Association Journal

Volumn 177, Issue 12, 2007, Pages 1526-

  Cassels, Alan K ^a  

^a UNIVERSITY OF VICTORIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

WART VIRUS VACCINE;

CANADA; CLINICAL TRIAL; HUMAN; LETTER; QUASI EXPERIMENTAL STUDY; UTERINE CERVIX CANCER; VACCINATION; VERRUCA VULGARIS; FEMALE; NOTE; POSTMARKETING SURVEILLANCE; PREVENTIVE HEALTH SERVICE; UTERINE CERVIX TUMOR; VIRUS INFECTION;

CANADA; FEMALE; HUMANS; IMMUNIZATION PROGRAMS; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PRODUCT SURVEILLANCE, POSTMARKETING; UTERINE CERVICAL NEOPLASMS;

EID: 37049005371     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.1070129     Document Type: Letter

References (3)

1. Lippman A, Melnychuk R, Shimmin C, et al. Human papillomavirus, vaccines and women's health: questions and cautions. CMAJ 2007;177:484-7.
2. Hart DP. A change in scientific approach: from alternation to randomized allocation in clinical trials in the 1940s. BMJ 1999;319:572-3.
3. Fung-Kee-Fung M, Rosen B, Murphy J, et al. HPV vaccine: a new era in cervical cancer prevention. Globe and Mail [Toronto] 2007 Sep 11;Sect A:21.